Low temperature photothermal therapy: Advances and perspectives

K Yang, S Zhao, B Li, B Wang, M Lan, X Song - Coordination Chemistry …, 2022 - Elsevier
Photothermal therapy (PTT) has received increasing attention due to its high selectivity, non-
invasiveness, negligible drug resistance, oxygen independence, and minimal side effects. In …

The role of apoptosis in cancer development and treatment response

JM Brown, LD Attardi - Nature reviews cancer, 2005 - nature.com
The inactivation of programmed cell death, or apoptosis, is central to the development of
cancer. This disabling of apoptotic responses might be a major contributor both to treatment …

Survivin: a unique target for tumor therapy

H Garg, P Suri, JC Gupta, GP Talwar, S Dubey - Cancer cell international, 2016 - Springer
Survivin is the smallest member of the Inhibitor of apoptosis (IAP) family of proteins, involved
in inhibition of apoptosis and regulation of cell cycle. These functional attributes make …

A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription

KH Emami, C Nguyen, H Ma, DH Kim… - Proceedings of the …, 2004 - National Acad Sciences
Inherited and somatic mutations in the adenomatous polyposis coli occur in most colon
cancers, leading to activation of β-catenin-responsive genes. To identify small molecule …

Targeting the cell cycle: a new approach to cancer therapy

GK Schwartz, MA Shah - Journal of clinical oncology, 2005 - ascopubs.org
The cell cycle represents a series of tightly integrated events that allow the cell to grow and
proliferate. Critical parts of the cell cycle machinery are the cyclin-dependent kinases …

Taxol®: The First Microtubule Stabilizing Agent

CPH Yang, SB Horwitz - International journal of molecular sciences, 2017 - mdpi.com
Taxol®, an antitumor drug with significant activity, is the first microtubule stabilizing agent
described in the literature. This short review of the mechanism of action of Taxol® …

The inhibitors of apoptosis (IAPs) as cancer targets

AM Hunter, EC LaCasse, RG Korneluk - Apoptosis, 2007 - Springer
Apoptosis has been accepted as a fundamental component in the pathogenesis of cancer,
in addition to other human diseases including neurodegeneration, coronary disease and …

IAP-targeted therapies for cancer

EC LaCasse, DJ Mahoney, HH Cheung, S Plenchette… - Oncogene, 2008 - nature.com
DNA damage, chromosomal abnormalities, oncogene activation, viral infection, substrate
detachment and hypoxia can all trigger apoptosis in normal cells. However, cancer cells …

Death receptors in chemotherapy and cancer

KM Debatin, PH Krammer - Oncogene, 2004 - nature.com
Apoptosis, the cell's intrinsic death program, is a key regulator of tissue homeostasis. An
imbalance between cell death and proliferation may result in tumor formation. Also, killing of …

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts

T Nakahara, M Takeuchi, I Kinoyama, T Minematsu… - Cancer research, 2007 - AACR
Various accumulating evidence suggests that survivin, a member of the inhibitor of
apoptosis (IAP) family, plays an important role in drug resistance and cancer cell survival in …